Tagged with AI

Spain The following infographic shows the main locations of the pharma sector in Spain, as well as the number of companies based in each region of the country.

Spain The following ranking comes from April 2014, and provides a snapshot of the current top players in the Spanish pharma sector.

Spain Spain’s public expenditure on pharmaceuticals is today at the same level that it was in 1993 – the lowest in 20 years.

pain management Mundipharma Malaysia’s country manager discusses his company’s aim to become a reference in Malaysia for pain management, on the back of the tremendous 48 percent growth of the business last year.    Mundipharma has recently entered a booming Malaysian pharmaceutical sector. What are your first impressions of the Malaysian market? Malaysia’s pharmaceutical sector…

CNS Lundbeck’s country manager gives a thorough overview of CNS disorders in Malaysia and states: “It is important to remind everyone that mental health conditions or brain diseases are not to be overlooked.” While this is a challenge, it also represents an opportunity for Lundbeck to provide best-in-line products to patients.…

cost containment “Cost containment measures are not just a Polish story, but a European reality,” says Marcin Hanczaruk, general manager at Amgen. “The Reimbursement Act is a real revolution, but it has brought both benefits and shortcomings. One consequence is that Poland has the lowest average price of medicine in the European…

Spain Owned completely by the LEO Foundation, LEO Pharma is an extremely patient-centric company focused primarily in the dermatology area. Kristian Hart-Hansen, general manager of LEO Pharma Spain, discusses the challenges in adapting to the country’s regional peculiarities and the subsidiary’s greater commitment to a much more stakeholder-focused approach. What were…

Taiwan This graph shows the revenues from the biotech sector in Taiwan between 2004 and 2012, broken down to show applied biotech, pharmaceuticals and medical devices.

Taiwan This graph looks at the market growth in the Taiwanese pharmaceutical sector since 2007, and predicts the growth rate until 2017, estimating a CAGR of 4.62 percent.

Taiwan This graph shows the total revenues and market value of the Taiwanese biotech sector between 2007 and 2013, as well as the number of listed companies in that sector over the same period.

china Signed in June 2010, the Economic Cooperation Framework Agreement (ECFA) between Taiwan and China was set to reduce tariffs and commercial barriers between the two countries. Obviously, such a deal means a lot to Taiwanese companies; arguably much more than it does to Chinese businesses. But just because the agreement…

chronic pain Bene Farmacêutica was established in 2009 to expand the supply and presence of Bene-Arzneimittel in Portugal, having already sold products in the country for several decades. The affiliate’s managing director, Frank Tischler, outlines Bene Farmacêutica’s entrance into Portugal and discusses the importance of adding value to brands in an environment…